{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-023367","form_type":"8-K","ticker":"GTBP","cik":"0000109657","company_name":"GT Biopharma, Inc.","filed_at":"2023-07-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.135020+00:00","generated_at":"2026-06-13T12:30:43.490576+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"GT Biopharma annual meeting elects four directors, ratifies auditor","bullets":["Elected directors Michael Breen, Rajesh Shrotriya, Bruce Wendel, and Charles Casamento with majority for votes.","Ratified Weinberg & Company as independent auditor for 2023: 19,823,634 for, 849,463 against.","Advisory say-on-pay passed: 8,916,400 for, 2,034,860 against, 13,805 abstain, 9,736,535 broker non-votes.","Quorum of 55.2% represented at meeting (20,701,600 of 37,493,065 shares outstanding)."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-023367","json":"https://secwatch.observer/filing/0001493152-23-023367.json","markdown":"https://secwatch.observer/filing/0001493152-23-023367.md","text":"https://secwatch.observer/filing/0001493152-23-023367.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/109657/000149315223023367/0001493152-23-023367-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/109657/000149315223023367/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T12:30:43.490576+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"185ba438ed19330000dda61c8054970ede68d8b1","claim":"GT Biopharma, Inc. shareholders approved Non-binding advisory vote endorsing the Registrant's executive compensation at the 2023-06-28 meeting.","evidence_excerpt":"For Against Abstain Broker Non-Votes 8,916,400 2,034,860 13,805 9,736,535","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/109657/000149315223023367/0001493152-23-023367-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-28"}],"fact_type":"shareholder_vote"},{"claim_id":"b4fa901578857c008826bcfe107680fb05f4af69","claim":"GT Biopharma, Inc. shareholders approved Ratification of the appointment of Weinberg & Company, P.A. as the Registrant's independent accountants for the year ending December 31, 2023 at the 2023-06-28 meeting.","evidence_excerpt":"For Against Abstain 19,823,634 849,463 28,503","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/109657/000149315223023367/0001493152-23-023367-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-28"}],"fact_type":"shareholder_vote"},{"claim_id":"eee349db0a2b47cf221725a368a01087a2222b79","claim":"GT Biopharma, Inc. shareholders approved Election of four members of the Board of Directors at the 2023-06-28 meeting.","evidence_excerpt":"Director For Withheld Michael Breen 9,817,096 1,147,969 Rajesh Shrotriya, M.D. 9,728,749 1,236,316 Bruce Wendel 7,757,208 3,207,857 Charles J. Casamento 9,266,209 1,698,856","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/109657/000149315223023367/0001493152-23-023367-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-28"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}